Production (Stage)
Thermo Fisher Scientific Inc.
TMO
$393.66
-$6.82-1.70%
NYSE
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.51B | 6.34B | 6.14B | 6.22B | 6.03B |
| Total Depreciation and Amortization | 2.98B | 3.11B | 3.20B | 3.32B | 3.38B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -335.00M | -397.00M | -985.00M | -902.00M | -698.00M |
| Change in Net Operating Assets | -1.02B | -379.00M | 750.00M | 711.00M | 209.00M |
| Cash from Operations | 8.14B | 8.67B | 9.10B | 9.35B | 8.93B |
| Capital Expenditure | -1.42B | -1.40B | -1.33B | -1.39B | -1.37B |
| Sale of Property, Plant, and Equipment | 65.00M | 57.00M | 51.00M | 97.00M | 85.00M |
| Cash Acquisitions | -3.13B | -3.13B | -3.13B | -909.00M | -956.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 144.00M | -1.37B | -1.83B | -1.64B | -1.79B |
| Cash from Investing | -4.34B | -5.84B | -6.24B | -3.84B | -4.03B |
| Total Debt Issued | 2.84B | 1.20B | 3.68B | 7.15B | 7.74B |
| Total Debt Repaid | -4.45B | -3.61B | -4.89B | -5.28B | -7.19B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.00B | -4.00B | -3.00B | -3.00B | -3.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -597.00M | -583.00M | -570.00M | -555.00M | -541.00M |
| Other Financing Activities | 130.00M | 194.00M | 225.00M | 176.00M | 145.00M |
| Cash from Financing | -5.07B | -6.79B | -4.55B | -1.51B | -2.85B |
| Foreign Exchange rate Adjustments | -76.00M | -91.00M | 192.00M | -56.00M | -29.00M |
| Miscellaneous Cash Flow Adjustments | 1.00M | 0.00 | 1.00M | 1.00M | -- |
| Net Change in Cash | -1.35B | -4.06B | -1.50B | 3.94B | 2.02B |